Leaders Creating Leaders for Tomorrow

Graduate Student Directory


Asmita Priyadarshini Khatiwada

Asmita Priyadarshini Khatiwada

Degree Program: Ph.D., Health Outcomes Research and Policy
Anticipated Graduation: 2027
Advisor: Dr. Surachat Ngorsuraches
Email: apk0022@auburn.edu


Bio

Education:

  • B. Pharm - Tribhuvan University (Nepal), 2016
  • M. Pharm, Pharmacy Practice - JSS College of Pharmacy (India), 2019

Research Interests

  • Pharmaceutical economics and policy
  • Other research interests include value assessment, cost-effectiveness studies, patient preference of populations with chronic conditions and rare diseases, and access to affordable medicines.

Active Research

  • Cost-effectiveness study of NASH treatment
  • Cost effectiveness study of Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
  • Patient Preference of NASH/NAFLD tests among Type 2 Diabetes Patients

Publications

  • Yang H, Khatiwada AP, Curtis JR, et al. Assessing activity limitations experienced by persons with rheumatoid arthritis to inform appropriate selection of patient-reported outcomes measures: a qualitative study. J Patient Rep Outcomes. 2025;9(1):129.
  • Alfayoumi I, Khatiwada AP, Ngorsuraches S. Cost-Effectiveness Analysis of Toripalimab Plus Axitinib for Patients with Advanced Renal Cell Carcinoma in the United States. Clin Drug Investig. 2025;45(8):537-549. doi:10.1007/s40261-025-01464-5
  • Khatiwada, A. P., Kamel, A. M. A., Chaiyakunapruk, N., & Ngorsuraches, S. (2025). Cost-effectiveness studies of brexu-cel for relapsed/refractory B-cell acute lymphoblastic leukemia and mantle cell lymphoma: a systematic review. Expert Review of Pharmacoeconomics & Outcomes Research25(3), 323–335. https://doi.org/10.1080/14737167.2024.2438631
  • Khatiwada, A. P., Genie, M. G., Gebremariam, A. G., Lai, T. C., Poudel, N., & Ngorsuraches, S. (2023). Vaccination and non-pharmaceutical interventions during COVID-19: Impact on health and non-health outcomes in the US. Health Policy and Technology, 100792. https://doi.org/10.1016/j.hlpt.2023.100792
  • Qian, J., Khatiwada, A. P., & Xue, X. Did the 2021 federal change in the practice guidelines for the administration of buprenorphine for treating opioid use disorder increase buprenorphine prescription dispensing in the Medicaid population? The American Journal on Addictions. https://doi.org/10.1111/ajad.13505

Last Updated: May 15, 2026
Back to Top